SCHEMBL20737176

SCHEMBL20737176

c1ccc(-c2ccc(-c3cc4c(c5ccccc35)-c3ccc5ccccc5c3C43c4ccccc4-c4ccccc43)cn2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.41
KDM4E B2RXH2 3/20 0.35
TP53 P04637 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MAPK1 P28482 2/20 0.35
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 1/20 0.35
HTR2C P28335 1/20 0.34
TGFBR1 P36897 2/20 0.33
HPGDS O60760 2/20 0.33
CYP2C9 P11712 1/20 0.32
CCR1 P32246 2/20 0.32
CCR5 P51681 2/20 0.32
CCR8 P51685 2/20 0.32
LMNA P02545 1/20 0.32
ALPL P05186 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737224 0.90 PDK2 (0.43) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20736079 0.90 PDK2 (0.41) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL27250730 0.88 PDK2 (0.37) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL27250518 0.87 PDK2 (0.40) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20736078 0.87 KDM4E (0.41) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20735831 0.87 PDK2 (0.36) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20737166 0.87 PDK2 (0.38) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20737168 0.87 PDK2 (0.40) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20737273 0.85 PDK2 (0.42) PDK2KDM4ETP53SMN1; SMN2MAPK1
SCHEMBL20737175 0.85 KDM4E (0.39) PDK2KDM4ETP53SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.